In studies conducted in the Asian population, a higher prevalence of patients with T2DM with severe insulinopenia has been observed, with insulin treatment in early stages, lower β-cell function, lower insulin resistance, and lower BMI, especially among the Indian and Chinese populations compared to the European population. The gene discussed is INS; the disease is type 2 diabetes mellitus.